Bangolo AI, Wadhwani N. Comprehensive analysis of the impact of primary percutaneous coronary intervention on patients with ST-segment elevation myocardial infarction. World J Exp Med 2024; 14(4): 94845 [PMID: 39713076 DOI: 10.5493/wjem.v14.i4.94845]
Corresponding Author of This Article
Ayrton I Bangolo, MBBS, MD, Doctor, Department of Internal Medicine, Palisades Medical Center, 7600 River Road, North Bergen, NJ 07047, United States. ayrtonbangolo@yahoo.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Exp Med. Dec 20, 2024; 14(4): 94845 Published online Dec 20, 2024. doi: 10.5493/wjem.v14.i4.94845
Comprehensive analysis of the impact of primary percutaneous coronary intervention on patients with ST-segment elevation myocardial infarction
Ayrton I Bangolo, Nikita Wadhwani
Ayrton I Bangolo, Nikita Wadhwani, Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
Author contributions: Bangolo AI and Wadhwani N contributed significantly to the conception of this scholarly work, interpretation of data, drafting of initial manuscript, and submission of its revised version.
Conflict-of-interest statement: All authors have no conflicts of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ayrton I Bangolo, MBBS, MD, Doctor, Department of Internal Medicine, Palisades Medical Center, 7600 River Road, North Bergen, NJ 07047, United States. ayrtonbangolo@yahoo.com
Received: March 26, 2024 Revised: September 14, 2024 Accepted: September 30, 2024 Published online: December 20, 2024 Processing time: 218 Days and 19.9 Hours
Abstract
This comprehensive analysis by Saeed and Faeq investigates the impact of primary percutaneous coronary intervention (pPCI) on mortality among patients with ST-segment elevation myocardial infarction (STEMI) at the Erbil Cardiac Center. Analyzing data from 96 consecutive STEMI patients, the study identified significant predictors of in-hospital mortality, emphasizing the critical impact of time of hospital arrival post-symptom onset on overall prognosis. Findings indicate that factors such as atypical presentation, cardiogenic shock, chronic kidney disease, and specific coronary complications are associated with higher mortality rates. The study underscores the necessity of prompt medical intervention for improving survival outcomes in STEMI patients, especially in the high-risk subgroup. This research offers valuable insights into optimizing STEMI management and enhancing patient survival rates through effective and timely pPCI.
Core Tip: This study by Saeed and Faeq reveals the significant impact of timely primary percutaneous coronary intervention on mortality reduction in ST-segment elevation myocardial infarction patients. The analysis showed that chronic kidney disease, specific culprit coronary lesions, and an atypical presentation characterized by presence of either syncope, cardiogenic shock, or ventricular arrhythmias on arrival were predictive of post-percutaneous coronary intervention mortality.
